|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
|
US5436146A
(en)
|
1989-09-07 |
1995-07-25 |
The Trustees Of Princeton University |
Helper-free stocks of recombinant adeno-associated virus vectors
|
|
US7101993B1
(en)
|
1990-01-11 |
2006-09-05 |
Isis Pharmaceuticals, Inc. |
Oligonucleotides containing 2′-O-modified purines
|
|
US6268213B1
(en)
|
1992-06-03 |
2001-07-31 |
Richard Jude Samulski |
Adeno-associated virus vector and cis-acting regulatory and promoter elements capable of expressing at least one gene and method of using same for gene therapy
|
|
US5869305A
(en)
|
1992-12-04 |
1999-02-09 |
The University Of Pittsburgh |
Recombinant viral vector system
|
|
US5478745A
(en)
|
1992-12-04 |
1995-12-26 |
University Of Pittsburgh |
Recombinant viral vector system
|
|
NZ261277A
(en)
|
1993-02-05 |
1997-04-24 |
Laporte Group Australia Ltd |
Slag defoaming composition comprising a carbon source; an exothermic material (eg aluminium) and a dense inert granular material (eg calcium silicate)
|
|
US5830462A
(en)
|
1993-02-12 |
1998-11-03 |
President & Fellows Of Harvard College |
Regulated transcription of targeted genes and other biological events
|
|
US6140120A
(en)
|
1993-02-12 |
2000-10-31 |
Board Of Trustees Of Leland Stanford Jr. University |
Regulated transcription of targeted genes and other biological events
|
|
US5869337A
(en)
|
1993-02-12 |
1999-02-09 |
President And Fellows Of Harvard College |
Regulated transcription of targeted genes and other biological events
|
|
US5834266A
(en)
|
1993-02-12 |
1998-11-10 |
President & Fellows Of Harvard College |
Regulated apoptosis
|
|
US20020173474A1
(en)
|
1993-02-12 |
2002-11-21 |
President And Fellows Of Harvard College |
Methods & materials involving dimerization-mediated regulation of biological events
|
|
WO1994018317A1
(en)
|
1993-02-12 |
1994-08-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
Regulated transcription of targeted genes and other biological events
|
|
US6972193B1
(en)
|
1993-02-12 |
2005-12-06 |
Board Of Trustees Of Leland Stanford Junior University |
Regulated transcription of targeted genes and other biological events
|
|
US6150137A
(en)
|
1994-05-27 |
2000-11-21 |
Ariad Pharmaceuticals, Inc. |
Immunosuppressant target proteins
|
|
US6476200B1
(en)
|
1994-06-27 |
2002-11-05 |
The Johns Hopkins University |
Mammalian proteins that bind to FKBP12 in a rapamycin-dependent fashion
|
|
US6204059B1
(en)
|
1994-06-30 |
2001-03-20 |
University Of Pittsburgh |
AAV capsid vehicles for molecular transfer
|
|
US6150527A
(en)
|
1994-08-18 |
2000-11-21 |
Ariad Pharmaceuticals, Inc. |
Synthetic multimerizing agents
|
|
JP4470226B2
(ja)
|
1994-08-18 |
2010-06-02 |
アリアド・ファーマシューティカルズ・インコーポレイテッド |
新規な多量体化剤
|
|
US6133456A
(en)
|
1994-08-18 |
2000-10-17 |
Ariad Gene Therapeutics, Inc. |
Synthetic multimerizing agents
|
|
US5786464C1
(en)
|
1994-09-19 |
2012-04-24 |
Gen Hospital Corp |
Overexpression of mammalian and viral proteins
|
|
US6326166B1
(en)
|
1995-12-29 |
2001-12-04 |
Massachusetts Institute Of Technology |
Chimeric DNA-binding proteins
|
|
AU719001B2
(en)
|
1994-12-29 |
2000-05-04 |
Massachusetts Institute Of Technology |
Chimeric DNA-binding proteins
|
|
US6166197A
(en)
|
1995-03-06 |
2000-12-26 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds having pyrimidine nucleotide (S) with 2'and 5 substitutions
|
|
US5741683A
(en)
|
1995-06-07 |
1998-04-21 |
The Research Foundation Of State University Of New York |
In vitro packaging of adeno-associated virus DNA
|
|
US6187757B1
(en)
|
1995-06-07 |
2001-02-13 |
Ariad Pharmaceuticals, Inc. |
Regulation of biological events using novel compounds
|
|
US5811524A
(en)
|
1995-06-07 |
1998-09-22 |
Idec Pharmaceuticals Corporation |
Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
|
|
US6506379B1
(en)
|
1995-06-07 |
2003-01-14 |
Ariad Gene Therapeutics, Inc. |
Intramuscular delivery of recombinant AAV
|
|
WO1996041865A1
(en)
|
1995-06-07 |
1996-12-27 |
Ariad Gene Therapeutics, Inc. |
Rapamcycin-based regulation of biological events
|
|
US6093570A
(en)
|
1995-06-07 |
2000-07-25 |
The University Of North Carolina At Chapel Hill |
Helper virus-free AAV production
|
|
AU2192797A
(en)
|
1996-02-28 |
1997-09-16 |
Ariad Gene Therapeutics, Inc. |
Synthetic derivatives of rapamycin as multimerising agents for chimeric proteins with immunophilin derived domains
|
|
US6723531B2
(en)
|
1996-04-05 |
2004-04-20 |
The Salk Institute For Biological Studies |
Method for modulating expression of exogenous genes in mammalian systems, and products related thereto
|
|
AU735648B2
(en)
|
1996-07-12 |
2001-07-12 |
Ariad Pharmaceuticals, Inc. |
Materials and method for treating or preventing pathogenic fungal infection
|
|
DE69837913T2
(de)
|
1997-04-01 |
2008-02-07 |
Solexa Ltd., Saffron Walden |
Verfahren zur vervielfältigung von nukleinsäure
|
|
DE69824859T2
(de)
|
1997-04-14 |
2005-08-04 |
Cell Genesys, Inc., Foster City |
Methoden zur erhöhung der effizienz rekombinanter aav produkte
|
|
EP1017829A2
(en)
|
1997-08-26 |
2000-07-12 |
Ariad Gene Therapeutics, Inc. |
Fusion proteins comprising a dimerization, trimerization or tetramerization domain and an additional heterologous transcription activation, transcription repression, dna binding or ligand binding domain
|
|
US6479653B1
(en)
|
1997-08-26 |
2002-11-12 |
Ariad Gene Therapeutics, Inc. |
Compositions and method for regulation of transcription
|
|
US6015709A
(en)
|
1997-08-26 |
2000-01-18 |
Ariad Pharmaceuticals, Inc. |
Transcriptional activators, and compositions and uses related thereto
|
|
CA2303482A1
(en)
|
1997-08-27 |
1999-03-04 |
Ariad Gene Therapeutics, Inc. |
Chimeric transcriptional activators and compositions and uses related thereto
|
|
WO1999036553A2
(en)
|
1998-01-15 |
1999-07-22 |
Ariad Gene Therapeutics, Inc. |
Regulation of biological events using multimeric chimeric proteins
|
|
US6984635B1
(en)
|
1998-02-13 |
2006-01-10 |
Board Of Trustees Of The Leland Stanford Jr. University |
Dimerizing agents, their production and use
|
|
CA2319492A1
(en)
|
1998-02-13 |
1999-08-19 |
President And Fellows Of Harvard College |
Novel dimerizing agents, their production and use
|
|
US6333318B1
(en)
|
1998-05-14 |
2001-12-25 |
The Salk Institute For Biological Studies |
Formulations useful for modulating expression of exogenous genes in mammalian systems, and products related thereto
|
|
EP1080218A1
(en)
|
1998-05-27 |
2001-03-07 |
University of Florida |
Method of preparing recombinant adeno-associated virus compositions by using an iodixanol gradient
|
|
US6258603B1
(en)
|
1998-06-17 |
2001-07-10 |
Rohm And Haas Company |
Ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
|
|
US6210892B1
(en)
|
1998-10-07 |
2001-04-03 |
Isis Pharmaceuticals, Inc. |
Alteration of cellular behavior by antisense modulation of mRNA processing
|
|
US6221349B1
(en)
|
1998-10-20 |
2001-04-24 |
Avigen, Inc. |
Adeno-associated vectors for expression of factor VIII by target cells
|
|
US6200560B1
(en)
|
1998-10-20 |
2001-03-13 |
Avigen, Inc. |
Adeno-associated virus vectors for expression of factor VIII by target cells
|
|
US7109317B1
(en)
|
1998-11-06 |
2006-09-19 |
President And Fellows Of Harvard College |
FK506-based regulation of biological events
|
|
DE69941905D1
(de)
|
1998-11-10 |
2010-02-25 |
Univ North Carolina |
Virusvektoren und verfahren für ihre herstellung und verabreichung.
|
|
ES2308989T3
(es)
|
1999-08-09 |
2008-12-16 |
Targeted Genetics Corporation |
Aumento de la expresion de una secuencia nucleotidica heterologa a partir de vectores viricos recombinantes que contienen una secuencia que forman pares de bases intracatenarios.
|
|
US7067526B1
(en)
|
1999-08-24 |
2006-06-27 |
Ariad Gene Therapeutics, Inc. |
28-epirapalogs
|
|
US6780639B1
(en)
|
1999-08-24 |
2004-08-24 |
Universite Libre De Bruxelles |
Antibiotic inducible/repressible genetic construct for gene therapy or gene immunization
|
|
IL147803A0
(en)
|
1999-08-24 |
2002-08-14 |
Ariad Gene Therapeutics Inc |
28-epirapalogs
|
|
JP3961737B2
(ja)
|
2000-02-29 |
2007-08-22 |
株式会社小糸製作所 |
車両用灯具およびその製造方法
|
|
CA2404253C
(en)
|
2000-03-22 |
2014-05-13 |
Rohm And Haas Company |
Novel ecdysone receptor-based inducible gene expression system
|
|
US20040033600A1
(en)
|
2001-03-21 |
2004-02-19 |
Palli Subba Reddy |
Ecdysone receptor-based inducible gene expression system
|
|
EP1286703B1
(en)
|
2000-06-01 |
2009-08-05 |
University Of North Carolina At Chapel Hill |
Methods and compounds for controlled release of recombinant parvovirus vectors
|
|
US8105825B2
(en)
|
2000-10-03 |
2012-01-31 |
Intrexon Corporation |
Multiple inducible gene regulation system
|
|
JP4328094B2
(ja)
|
2001-02-20 |
2009-09-09 |
イントレクソン・コーポレイション |
新規置換突然変異体受容体および核受容体−ベースの誘導性遺伝子発現システムにおけるその使用
|
|
ES2385598T3
(es)
|
2001-02-20 |
2012-07-27 |
Intrexon Corporation |
Sistema novedoso de expresión génica inducible basado en el receptor de ecdisona/receptor X retinoide de invertebrado
|
|
ES2390070T3
(es)
|
2001-02-20 |
2012-11-06 |
Intrexon Corporation |
Nuevos receptores mutantes de sustitución y su uso en un sistema de expresión génica inducible basado en receptores nucleares
|
|
WO2002066614A2
(en)
|
2001-02-20 |
2002-08-29 |
Rheogene Holdings, Inc. |
Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system
|
|
CA2447240C
(en)
|
2001-05-18 |
2013-02-19 |
Wisconsin Alumni Research Foundation |
Method for the synthesis of dna sequences
|
|
NZ618298A
(en)
|
2001-11-13 |
2015-04-24 |
Univ Pennsylvania |
A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
|
|
PT2359869T
(pt)
|
2001-12-17 |
2019-04-16 |
Univ Pennsylvania |
Sequências do vírus adeno-associado (aav) do serotipo 8, vetores contendo as mesmas, e utilizações destas
|
|
WO2003104413A2
(en)
|
2002-06-05 |
2003-12-18 |
University Of Florida |
Production of pseudotyped recombinant aav virions
|
|
US20080050357A1
(en)
|
2003-08-01 |
2008-02-28 |
Claes Gustafsson |
Systems and Methods for Antibody Engineering
|
|
US8005620B2
(en)
|
2003-08-01 |
2011-08-23 |
Dna Twopointo Inc. |
Systems and methods for biopolymer engineering
|
|
EP2292780B1
(en)
|
2003-09-30 |
2017-08-23 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses thereof
|
|
US20060246079A1
(en)
|
2003-11-14 |
2006-11-02 |
Morrow Phillip R |
Neutralizing human antibodies to anthrax toxin
|
|
US7935510B2
(en)
|
2004-04-30 |
2011-05-03 |
Intrexon Corporation |
Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
|
|
US7838657B2
(en)
|
2004-12-03 |
2010-11-23 |
University Of Massachusetts |
Spinal muscular atrophy (SMA) treatment via targeting of SMN2 splice site inhibitory sequences
|
|
EP2359865B1
(en)
|
2005-04-07 |
2013-10-02 |
The Trustees of The University of Pennsylvania |
Method of increasing the function of an AAV vector
|
|
CN101212988A
(zh)
|
2005-05-02 |
2008-07-02 |
建新公司 |
神经代谢疾病的基因治疗
|
|
JP4495210B2
(ja)
|
2005-06-09 |
2010-06-30 |
パナソニック株式会社 |
振幅誤差補償装置及び直交度誤差補償装置
|
|
WO2007002390A2
(en)
|
2005-06-23 |
2007-01-04 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for modulation of smn2 splicing
|
|
US8877187B2
(en)
|
2005-07-25 |
2014-11-04 |
Avianax, Llc |
Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases
|
|
EP2007795B1
(en)
|
2006-03-30 |
2016-11-16 |
The Board Of Trustees Of The Leland Stanford Junior University |
Aav capsid proteins
|
|
CN101528916B
(zh)
|
2006-04-28 |
2013-09-04 |
宾夕法尼亚大学托管会 |
规模可调的aav生产方法
|
|
PL2489733T3
(pl)
|
2006-06-07 |
2019-08-30 |
Genzyme Corporation |
Terapia genowa w stwardnieniu zanikowym bocznym i innych zaburzeniach rdzenia kręgowego
|
|
ES2391789T3
(es)
|
2006-10-03 |
2012-11-29 |
Genzyme Corporation |
Terapia génica para la esclerosis lateral amiotrófica y otros trastornos de la médula espinal
|
|
BRPI0807952A2
(pt)
|
2007-02-20 |
2014-06-10 |
Anaptysbio Inc |
Sistemas de hipermutação somática
|
|
EP2125886A2
(en)
|
2007-03-13 |
2009-12-02 |
Humabs LLC |
Antibodies against h5n1 strains of influenza a virus
|
|
WO2008124934A1
(en)
|
2007-04-17 |
2008-10-23 |
National Research Council Of Canada |
Constructs for enhancement of gene expression in muscle
|
|
US7879326B2
(en)
|
2007-06-15 |
2011-02-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Human neutralizing monoclonal antibodies to H5N1 influenza A virus
|
|
MX2010005244A
(es)
|
2007-11-12 |
2010-10-25 |
Theraclone Sciences Inc |
Composiciones y métodos para la terapia y el diagnóstico de influenza.
|
|
EP3524619A1
(en)
|
2007-12-06 |
2019-08-14 |
Dana-Farber Cancer Institute, Inc. |
Antibodies against influenza virus and methods of use thereof
|
|
ITTO20080204A1
(it)
|
2008-03-17 |
2009-09-18 |
Pomona Biotechnologies Llc |
Anticorpi monoclonali atti a reagire con una pluralita di sottotipi del virus influenzale a
|
|
EP2698380A1
(en)
|
2008-03-28 |
2014-02-19 |
Sea Lane Biotechnologies, LLC |
Neutralizing molecules to viral antigens
|
|
ITTO20080398A1
(it)
|
2008-05-27 |
2009-11-28 |
Pomona Biotechnologies Llc |
Anticorpi monoclonali aventi proprieta' di cross-neutralizzazione omosubtipica per virus influenzali di tipo a sottotipo h1
|
|
EP2296700A2
(en)
|
2008-06-03 |
2011-03-23 |
Vaxin, Inc. |
Intranasal administration of receptor-binding ligands or genes encoding such ligands as a therapeutic regimen for mitigating infections caused by respiratory pathogens
|
|
RU2553325C2
(ru)
|
2008-07-25 |
2015-06-10 |
Институт Фо Ресёч Ин Биомедицин |
Нейтрализующие антитела против вируса гриппа а и их использование
|
|
US8871207B2
(en)
|
2008-07-25 |
2014-10-28 |
Humabs, LLC |
Neutralizing anti-influenza A virus antibodies and uses thereof
|
|
JP6087504B2
(ja)
|
2008-11-07 |
2017-03-01 |
マサチューセッツ インスティテュート オブ テクノロジー |
アミノアルコールリピドイドおよびその使用
|
|
US8211631B2
(en)
|
2008-12-18 |
2012-07-03 |
Wisconsin Alumni Research Foundation |
In vitro model of spinal muscular atrophy
|
|
DK3421603T3
(da)
|
2009-05-02 |
2022-01-10 |
Genzyme Corp |
Genterapi for neurodegenerative forstyrrelser
|
|
WO2010130636A1
(en)
|
2009-05-11 |
2010-11-18 |
Crucell Holland B.V. |
Human binding molecules capable of neutralizing influenza virus h3n2 and uses thereof
|
|
WO2010138263A2
(en)
|
2009-05-28 |
2010-12-02 |
University Of Massachusetts |
Novel aav 's and uses thereof
|
|
IT1395961B1
(it)
|
2009-06-01 |
2012-11-02 |
Pomona Biotechnologies Llc |
Anticorpi monoclonali come medicamento per il trattamento terapeutico e/o profilattico delle infezioni da virus influenzale a (h1n1) di origine suina (s-oiv)
|
|
KR20200047790A
(ko)
|
2009-06-17 |
2020-05-07 |
바이오젠 엠에이 인코포레이티드 |
대상에게서 ｓｍｎ２ 스플라이싱을 조정하기 위한 조성물 및 방법
|
|
WO2010151673A1
(en)
|
2009-06-25 |
2010-12-29 |
Medimmune, Llc |
Swine influenza hemagglutinin variants
|
|
US8598331B2
(en)
|
2009-09-28 |
2013-12-03 |
The University Of British Columbia |
CLDN5 mini-promoters
|
|
SG183929A1
(en)
|
2010-03-29 |
2012-10-30 |
Univ Pennsylvania |
Pharmacologically induced transgene ablation system
|
|
US9315825B2
(en)
|
2010-03-29 |
2016-04-19 |
The Trustees Of The University Of Pennsylvania |
Pharmacologically induced transgene ablation system
|
|
US8927514B2
(en)
|
2010-04-30 |
2015-01-06 |
City Of Hope |
Recombinant adeno-associated vectors for targeted treatment
|
|
WO2012115980A1
(en)
|
2011-02-22 |
2012-08-30 |
California Institute Of Technology |
Delivery of proteins using adeno-associated virus (aav) vectors
|
|
WO2012145572A1
(en)
|
2011-04-20 |
2012-10-26 |
The Trustees Of The University Of Pennsylvania |
Regimens and compositions for aav-mediated passive immunization of airborne pathogens
|
|
US20140127749A1
(en)
|
2011-04-21 |
2014-05-08 |
Arizona Borad Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizo |
Methods of protein production and compositions thereof
|
|
CA3107288A1
(en)
|
2011-06-08 |
2012-12-13 |
Translate Bio, Inc. |
Lipid nanoparticle compositions and methods for mrna delivery
|
|
FR2977562B1
(fr)
|
2011-07-06 |
2016-12-23 |
Gaztransport Et Technigaz |
Cuve etanche et thermiquement isolante integree dans une structure porteuse
|
|
US8961978B2
(en)
|
2011-07-14 |
2015-02-24 |
Crucell Holland B.V. |
Human binding molecules capable of neutralizing influenza A viruses of phylogenetic group 1 and phylogenetic group 2 and influenza B viruses
|
|
US9181328B2
(en)
|
2012-01-31 |
2015-11-10 |
Osaka University |
Human monoclonal antibodies broadly protective against influenza B virus and methods of using the same
|
|
CA2864879C
(en)
*
|
2012-02-17 |
2021-07-20 |
The Children's Hospital Of Philadelphia |
Aav vector compositions and methods for gene transfer to cells, organs and tissues
|
|
US8834881B2
(en)
|
2012-03-08 |
2014-09-16 |
Crucell Holland B.V. |
Human binding molecules capable of binding to and neutralizing influenza B viruses and uses thereof
|
|
HK1206601A1
(en)
*
|
2012-04-02 |
2016-01-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of biologics and proteins associated with human disease
|
|
WO2013155222A2
(en)
|
2012-04-10 |
2013-10-17 |
The Regents Of The University Of California |
Brain-specific enhancers for cell-based therapy
|
|
ES2862912T3
(es)
|
2012-04-18 |
2021-10-08 |
Childrens Hospital Philadelphia |
Composición y procedimientos para la transferencia genética de alta eficiencia utilizando variantes de cápside de VAA
|
|
BR112014029807A2
(pt)
|
2012-06-08 |
2017-06-27 |
Ethris Gmbh |
administração pulmonar de rna mensageiro
|
|
EP3536795A3
(en)
|
2012-06-21 |
2019-12-11 |
Association Institut de Myologie |
Widespread gene expression
|
|
ES2791778T3
(es)
|
2012-08-01 |
2020-11-05 |
Ikaika Therapeutics Llc |
Mitigación del daño tisular y la fibrosis a través de anticuerpos anti-LTBP4
|
|
US9719106B2
(en)
|
2013-04-29 |
2017-08-01 |
The Trustees Of The University Of Pennsylvania |
Tissue preferential codon modified expression cassettes, vectors containing same, and uses thereof
|
|
KR102116378B1
(ko)
*
|
2013-05-01 |
2020-06-01 |
젠자임 코포레이션 |
척수성 근위축증을 치료하기 위한 조성물 및 방법
|
|
DK3024497T3
(da)
|
2013-07-26 |
2021-04-12 |
Univ Iowa Res Found |
Fremgangsmåder og præparater til behandling af hjernesygdomme
|
|
EP3564379A1
(en)
*
|
2013-09-13 |
2019-11-06 |
California Institute of Technology |
Selective recovery
|
|
CA2928040A1
(en)
*
|
2013-10-22 |
2015-04-30 |
Shire Human Genetic Therapies, Inc. |
Cns delivery of mrna and uses thereof
|
|
CA2927366A1
(en)
|
2013-10-24 |
2015-04-30 |
Uniqure Ip B.V. |
Aav-5 pseudotyped vector for gene therapy for neurological diseases
|
|
EP3107582A4
(en)
|
2014-02-19 |
2018-02-14 |
Emergent BioSolutions Canada Inc. |
Ebola monoclonal antibodies
|
|
JP6983511B2
(ja)
|
2014-04-25 |
2021-12-17 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
脳中の転移乳癌および他の癌を処置するための方法および組成物
|
|
US10746742B2
(en)
*
|
2014-04-25 |
2020-08-18 |
Oregon Health & Science University |
Methods of viral neutralizing antibody epitope mapping
|
|
JP6741590B2
(ja)
|
2014-04-25 |
2020-08-19 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
コレステロールレベルを低下させるためのｌｄｌｒ変異体および組成物中でのそれらの使用
|
|
PE20170260A1
(es)
|
2014-05-02 |
2017-04-12 |
Genzyme Corp |
Vectores de aav para la terapia genica de la retina y el snc
|
|
PT3142750T
(pt)
|
2014-05-13 |
2020-09-22 |
Univ Pennsylvania |
Composições que compreendem aav expressando construções de anticorpos duplos e suas utilizações
|
|
KR20230067694A
(ko)
|
2014-09-24 |
2023-05-16 |
시티 오브 호프 |
고효율 게놈 편집을 위한 아데노-관련 바이러스 벡터 변이체 및 이의 방법
|
|
CA2963470A1
(en)
|
2014-10-03 |
2016-04-07 |
Massachusetts Institute Of Technology |
Antibodies that bind ebola glycoprotein and uses thereof
|
|
EA038407B1
(ru)
|
2015-02-05 |
2021-08-24 |
Янссен Вэксинс Энд Превеншн Б.В. |
Связывающие молекулы, направленные против гемагглютинина вируса гриппа, и пути их применения
|
|
MA48852A
(fr)
|
2015-05-13 |
2020-04-01 |
Univ Pennsylvania |
Expression médiée par aav d'anticorps anti-grippaux et leurs procédés d'utilisation
|
|
US11135313B2
(en)
|
2015-10-28 |
2021-10-05 |
The Trustees Of The University Of Pennsylvania |
Intrathecal administration of adeno-associated-viral vectors for gene therapy
|
|
WO2017100674A1
(en)
|
2015-12-11 |
2017-06-15 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for aav1
|
|
ES2918998T3
(es)
|
2015-12-11 |
2022-07-21 |
Univ Pennsylvania |
Método de purificación escalable para AAVrh10
|
|
US11098286B2
(en)
|
2015-12-11 |
2021-08-24 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for AAV9
|
|
EP3387117B1
(en)
|
2015-12-11 |
2022-11-23 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for aav8
|
|
US20180363000A1
(en)
|
2015-12-14 |
2018-12-20 |
The Trustees Of The University Of Pennsylvania |
Aav-anti pcsk9 antibody constructs and uses thereof
|
|
US20190002915A1
(en)
|
2015-12-14 |
2019-01-03 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for regulatable antibody expression
|
|
EP3394270A1
(en)
|
2015-12-14 |
2018-10-31 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated viral vectors useful in treatment of spinal muscular atropy
|
|
MA43968A
(fr)
|
2016-02-03 |
2018-12-12 |
Univ Pennsylvania |
Thérapie génique pour traiter la mucopolysaccharidose de type i
|
|
CA3033856A1
(en)
|
2016-08-15 |
2018-02-22 |
Genzyme Corporation |
Methods for detecting aav
|
|
US20190240328A1
(en)
|
2016-09-24 |
2019-08-08 |
The Trustees Of The University Of Pennsylvania |
Novel humanized anti-ebola antibodies useful in preventing ebola infections
|
|
WO2018160573A1
(en)
|
2017-02-28 |
2018-09-07 |
The Trustees Of The University Of Pennsylvania |
Influenza vaccines based on aav vectors
|
|
WO2018160582A1
(en)
|
2017-02-28 |
2018-09-07 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated virus (aav) clade f vector and uses therefor
|
|
JOP20190200A1
(ar)
*
|
2017-02-28 |
2019-08-27 |
Univ Pennsylvania |
تركيبات نافعة في معالجة ضمور العضل النخاعي
|